Abiopharma

🔍 Shirk Michael F (Executive)

Company: FULTON FINANCIAL CORP (FULT)

Report Date: 2026-06-01

Detailed Transactions and Holdings:

• Acquired 5,117 shares of $2.50 par value Common Stock (Direct)
  Date: 2026-06-01 | Code: M | equity_swap_involved: false | shares_owned_after: 25,038.23 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of $2.50 par value Common Stock (Direct)
  Date: 2026-06-01 | Code: H | nature_of_ownership: By Children | shares_owned_after: 10,551.02 | Footnotes: F2
• Holds 0 shares of $2.50 par value Common Stock (Direct)
  Date: 2026-06-01 | Code: H | nature_of_ownership: By JOS Credit Shelter Trust | shares_owned_after: 37,608.00
• Holds 0 shares of $2.50 par value Common Stock (Direct)
  Date: 2026-06-01 | Code: H | nature_of_ownership: By Spouse SEP Account | shares_owned_after: 2,756.00
• Holds 0 shares of $2.50 par value Common Stock (Direct)
  Date: 2026-06-01 | Code: H | nature_of_ownership: By Tipararee, LLC | shares_owned_after: 3,000.00
• Holds 0 shares of Depository shares-Non-Cumulative Perpetual Preferred Ser A (Direct)
  Date: 2026-06-01 | Code: H | shares_owned_after: 3,000.00 | Footnotes: F3
• Sold 5,117 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-01 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F4, F5, F5
• Acquired 4,222 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-01 | Code: A | equity_swap_involved: false | shares_owned_after: 4,222.00 | transaction_form_type: 4 | Footnotes: F4, F6, F6

Footnotes:

• F1: Includes 89.969804 shares acquired on January 15, 2026 and 83.883101 shares acquired on April 15, 2026 pursuant to dividend reinvestment.
• F2: Includes 99.0166 shares acquired on January 20, 2026 and 91.7691 shares acquired on April 20, 2026 pursuant to dividend reinvestment.
• F3: Shares held joint with spouse.
• F4: Each restricted stock unit represents a contingent right to receive one share of Fulton Financial Corporation common stock, $2.50 par value per share.
• F5: Represents 4,928 restricted stock units granted to the reporting person on June 1, 2025, together with 188.838338 accumulated dividend equivalents, for which the forfeiture restrictions lapsed on June 1, 2026. The common stock into which the restricted stock units were converted is reported in Table I of this Form 4.
• F6: The restricted stocks units, together with accumulated dividend equivalents, will convert to common stock on the first anniversary of the date of the grant or, at the election of the reporting person, in up to three equal annual installments beginning in January of the year following the year in which the reporting person retires or separates from the Fulton Financial Corporation Board of Directors.
• F7: Forfeiture restrictions lapse on the restricted stock units on the first anniversary of the date of grant, or earlier in accordance with the Fulton Financial Corporation Amended and Restated 2023 Director Equity Plan.